<DOC>
	<DOCNO>NCT00166829</DOCNO>
	<brief_summary>The purpose study understand whether pharmacokinetics tacrolimus influenced concurrent use sirolimus .</brief_summary>
	<brief_title>The Effect Sirolimus Pharmacokinetics Tacrolimus</brief_title>
	<detailed_description>The controlled clinical trial hold NTUH 2001 reveal bioavailability tacrolimus combine sirolimus lower report literature tacrolimus combine sirolimus . To determine difference due drug interaction sirolimus tacrolimus , control clinical trial propose . The purpose study understand whether pharmacokinetics tacrolimus influenced concurrent use sirolimus .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>De novo kidney transplant patient Aged 13 65 year Having aminotransferase concentration within 2 time upper limit normal Pregnancy Tuberculosis Hepatitis B C carrier status Human immunodeficiency viruspositive status Retransplantation multiorgan transplantation History rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2003</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>Mycophenolic acid</keyword>
	<keyword>Immunosuppressive Agents</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Transplantation</keyword>
</DOC>